Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Randomised controlled trial of metronidazole and probiotic preparation versus placebo in the treatment of irritable bowel syndrome
2004-002685-38Phase 2Completed
- Sponsor
- Yakult Honsha
- Start
- May 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in irritable bowel syndrome (IBS) comparing Metronidazole → probiotic supplement with Placebo (2 arms). Primary endpoint: Change in weekly irritable bowel severity score. Started May 2005; status: completed.
02
Drugs
metronidazole
03
Conditions
irritable bowel syndrome (IBS)
Beyond the preview
Go deeper on 2004-002685-38.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-002685-38.